Product Description
熔点:239-241°C储存条件:underinertgas(nitrogenorArgon)at2-8°C溶解度:DMSO(Slightly,Sonicated),Methanol(Slightly)形态:Solid颜色:Off-WhitetoPaleYellow稳定性:HygroscopicInChIChemicalbook:InChI=1/C20H18N2O4.ClH/c1-24-20(23)15-9-13-12-4-2-3-5-14(12)21-19(13)18(22-15)11-6-7-16-17(8-11)26-10-25-16;/h2-8,15,18,21-22H,9-10H2,1H3;1H/t15-,18-;/s3
AI Product Description
*The following content is generated by AI and is for reference only.
(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate is a sophisticated organic compound belonging to the class of tetrahydro-beta-carbolines. This molecule features a complex fused ring system comprising an indole moiety linked with a pyridine ring, substituted at the C1 position with a methylenedioxyphenyl group and at the C3 position with a methyl ester functionality. The specific stereochemistry indicated by the (1R,3R) designation suggests that this enantiomer possesses distinct three-dimensional properties compared to its diastereomers or racemic mixtures, which is critical for biological interactions. While a unique CAS registry number is not publicly indexed in standard commercial databases under this exact systematic name, it likely corresponds to a specialized intermediate or analog within the vast family of berberine-type alkaloids or synthetic derivatives thereof.
The primary utility of such compounds lies in medicinal chemistry and pharmaceutical research. Structurally related beta-carboline derivatives are renowned for their diverse pharmacological profiles, including potential neuroprotective, anticancer, antimicrobial, and anti-inflammatory activities. The presence of the benzo[d][1,3]dioxole (methylenedioxy) group often enhances lipophilicity and blood-brain barrier permeability, making these molecules promising candidates for treating central nervous system disorders. Furthermore, the chiral nature of the (1R,3R) isomer implies that it may exhibit higher binding affinity to specific biological targets, such as serotonin receptors or DNA topoisomerases, compared to non-specific isomers. Researchers utilize these precise structures as lead compounds in drug discovery programs to optimize potency and selectivity. Additionally, they serve as valuable tools in biochemical assays to study enzyme inhibition mechanisms or receptor-ligand dynamics. Due to their structural complexity, synthesis typically requires multi-step organic transformations involving condensation reactions and stereoselective reductions. As a specialized reagent, this compound is primarily intended for laboratory-scale investigation rather than direct consumer application. Its development contributes significantly to the understanding of structure-activity relationships (SAR) in heterocyclic chemistry, paving the way for novel therapeutic agents targeting difficult-to-treat diseases. Future studies may explore its metabolic stability and toxicity profile to determine its viability as a clinical candidate.
![(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](https://eimg.pharmasources.com/image/20250221/OXxRZ4j3Gu6LpalyiBF8i9GbNI8RF1YZJbzOFvtZ.png)
(All Rights Reserved)
![6,8-Dioxo-5,7-diazaspiro[3.4]octane-2-carboxylic acid](https://eimg.pharmasources.com/image/product/20250403/02effeb5a7639bc84ff1f3add3c0c64fjpg)
![8,16-Diazadispiro[6.1.6.2]heptadecan-17-one](https://eimg.pharmasources.com/image/product/20250403/ca91cba8b87e53fc879f8d8764873a40jpg)
![8-Oxa-1,3-diazaspiro[4.5]decane-2,4-dione](https://eimg.pharmasources.com/image/product/20250403/60fa7223d5a34f24138486ceea0ffb15jpg)
